Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 21% ± 7% | |
intestine | 6 studies | 26% ± 12% | |
lung | 6 studies | 28% ± 9% | |
brain | 6 studies | 30% ± 9% | |
eye | 5 studies | 25% ± 7% | |
pancreas | 3 studies | 38% ± 16% | |
kidney | 3 studies | 20% ± 4% | |
lymph node | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10599.18 | 1445 / 1445 | 100% | 43.11 | 183 / 183 |
ovary | 100% | 14190.59 | 180 / 180 | 100% | 28.85 | 430 / 430 |
breast | 100% | 10284.16 | 459 / 459 | 100% | 46.76 | 1117 / 1118 |
lung | 100% | 10487.33 | 577 / 578 | 100% | 36.14 | 1155 / 1155 |
prostate | 100% | 13756.04 | 245 / 245 | 100% | 33.43 | 501 / 502 |
brain | 100% | 6747.57 | 2633 / 2642 | 100% | 30.17 | 705 / 705 |
uterus | 100% | 14574.68 | 170 / 170 | 100% | 44.69 | 457 / 459 |
bladder | 100% | 11008.38 | 21 / 21 | 99% | 40.22 | 501 / 504 |
stomach | 100% | 8519.24 | 359 / 359 | 99% | 36.21 | 283 / 286 |
intestine | 100% | 11984.15 | 966 / 966 | 99% | 38.25 | 521 / 527 |
thymus | 100% | 13053.94 | 653 / 653 | 99% | 29.21 | 598 / 605 |
pancreas | 100% | 5297.29 | 328 / 328 | 98% | 28.04 | 175 / 178 |
adrenal gland | 100% | 10795.24 | 258 / 258 | 98% | 24.62 | 225 / 230 |
kidney | 100% | 9530.76 | 89 / 89 | 98% | 22.67 | 880 / 901 |
skin | 100% | 9660.55 | 1809 / 1809 | 97% | 31.94 | 458 / 472 |
liver | 100% | 5356.60 | 226 / 226 | 96% | 17.77 | 390 / 406 |
adipose | 100% | 9380.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10006.10 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.58 | 29 / 29 |
spleen | 100% | 12676.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 39.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.33 | 1 / 1 |
muscle | 100% | 5773.71 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 6161.21 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 17.14 | 75 / 80 |
peripheral blood | 79% | 6627.60 | 738 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0006397 | Biological process | mRNA processing |
GO_0051028 | Biological process | mRNA transport |
GO_0033120 | Biological process | positive regulation of RNA splicing |
GO_0000395 | Biological process | mRNA 5'-splice site recognition |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0097421 | Biological process | liver regeneration |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0016607 | Cellular component | nuclear speck |
GO_0035145 | Cellular component | exon-exon junction complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005737 | Cellular component | cytoplasm |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_0044547 | Molecular function | DNA topoisomerase binding |
GO_0003723 | Molecular function | RNA binding |
GO_0043422 | Molecular function | protein kinase B binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SRSF1 |
Protein name | Serine and arginine rich splicing factor 1 Serine and arginine rich splicing factor 1 (Splicing factor, arginine/serine-rich 1 (Splicing factor 2, alternate splicing factor), isoform CRA_f) Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit) Serine/arginine-rich splicing factor 1 (Splicing factor, arginine/serine-rich 1) Serine and arginine rich splicing factor 1 transcript variant 5 |
Synonyms | hCG_1774411 SFRS1 SF2 OK/SW-cl.3 SF2P33 ASF |
Description | FUNCTION: Plays a role in preventing exon skipping, ensuring the accuracy of splicing and regulating alternative splicing. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Can stimulate binding of U1 snRNP to a 5'-splice site-containing pre-mRNA. Binds to purine-rich RNA sequences, either the octamer, 5'-RGAAGAAC-3' (r=A or G) or the decamers, AGGACAGAGC/AGGACGAAGC. Binds preferentially to the 5'-CGAGGCG-3' motif in vitro. Three copies of the octamer constitute a powerful splicing enhancer in vitro, the ASF/SF2 splicing enhancer (ASE) which can specifically activate ASE-dependent splicing. Isoform ASF-2 and isoform ASF-3 act as splicing repressors. May function as export adapter involved in mRNA nuclear export through the TAP/NXF1 pathway. . |
Accessions | J3KTL2 ENST00000584668.5 ENST00000582730.6 [Q07955-3] ENST00000584773.5 ENST00000258962.5 [Q07955-1] Q07955 A0A2I7N9Y9 J3KSW7 J3QQV5 ENST00000583741.1 ENST00000585096.1 J3KSR8 ENST00000581979.5 [Q07955-3] |